Summary
Guardant Health, Inc. (GH) filed an 8-K on November 6, 2023, to report its financial results for the fiscal quarter ended September 30, 2023. The key information is contained within the accompanying press release, which details the company's performance and financial condition. Investors should note that this information is furnished and not deemed "filed" for certain regulatory purposes, though it is incorporated by reference into the 8-K. While the specific financial figures are not detailed within the 8-K text itself, the filing serves as the official channel for announcing these results. Investors relying on this report should access the furnished press release (Exhibit 99.1) for the actual revenue, earnings per share, and any updated guidance or strategic commentary provided by the company. This allows for a timely assessment of Guardant Health's recent operational success and its trajectory.
Key Highlights
- 1Guardant Health announced its Q3 2023 financial results via an 8-K filing on November 6, 2023.
- 2The 8-K filing incorporates by reference the full press release detailing the quarterly financial performance.
- 3Investors can find specific revenue, profitability, and operational metrics within the furnished press release (Exhibit 99.1).
- 4The information provided in this 8-K is furnished, not filed, for purposes of Section 18 of the Exchange Act.
- 5This filing is the official notification of Guardant Health's Q3 2023 financial outcomes.
- 6Accessing Exhibit 99.1 is crucial for a comprehensive understanding of the company's financial results.